Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-25 @ 1:49 PM
NCT ID: NCT03656692
Description: Treatment Emergent non-serious adverse events and all serious adverse events are reported. Treatment emergent adverse events are those that started or got worse after the first dose of study drug. Clinically significant change in vital signs, laboratory values and/or physical examinations are recorded as adverse events.
Frequency Threshold: 5
Time Frame: Up to 44 weeks
Study: NCT03656692
Study Brief: Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Acthar Gel Participants receive Acthar Gel 0 None 0 5 5 5 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Iris adhesions SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (23.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (23.0) View
Drug hypersensitivity SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA (23.0) View
Intraocular pressure increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (23.0) View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (23.0) View
Uveitis SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (23.0) View